|
|
- Howard McCormick
- 6 years ago
- Views:
Transcription
1
2
3
4
5
6
7
8
9
10
11 Meghan Ames Mrs. Matuszak KNH 406 March 18, 2010 Diabetes Case Study #4 Understanding the Disease and Pathophysiology 1) Define insulin. Describe its major functions within normal metabolism. Insulin is a hormone produced in the β cells of the pancreas. It is responsible for facilitating the movement of glucose from the blood into the body s muscle and fat cells. It is secreted in response to an increase in blood glucose. 2) What are the current opinions regarding the etiology of type 1 diabetes mellitus (DM)? Type 1 DM results from the autoimmune destruction of pancreatic cells preventing the synthesis and secretion of insulin. The trigger for autoimmune destruction is debated and hypotheses include environmental toxins or infections 3) What genes have been identified that indicate susceptibility to type 1 diabetes mellitus? Genes that influence the function of pancreatic β cells have been examined for possible links to T1DM. Additionally, genes related to functions influencing metabolic syndrome are being reviewed for a link to T2DM. For example, PPARγ is being reviewed for its possible role in insulin resistance. 4) After examining Susan s medical history, can you identify any risk factors for type 1 DM? Susan has a family hx of DM which is a risk factor in her development of the disease consider the potential genetic links of the disease. 5) What are the established diagnostic criteria for type 1 DM? How can the physicians distinguish between type 1 and type 2 DM? DM is usually diagnosed through an oral glucose tolerance test. T1DM can be diagnosed in individuals with a plasma glucose 200 mg/dl or a fasting plasma glucose 126 mg/dl when presented with additional symptoms, such as unexplained weight loss, pollydipsia, or polyuria. One distinction helpful in the diagnosis of DM is that T1DM is illustrated by sudden onset of symptoms, where T2DM is more gradual. Additionally, T2DM is almost always seen in conjunction with symptoms of metabolic syndrome. 6) Describe the metabolic events that led to Susan s symptoms (polyuria, polydipsia, polyphagia, weight loss, and fatigue) and integrate these with the pathophysiology of the disease. Glycosuria and polyuria result from the excretion of excess blood glucose that has built up because of a lack of insulin in the body. This polyuria results in an excessive water loss, leading to polydipsia, polyphagia, and weight loss. Fatigue is a symptom of muscle and fat cells that are starved for energy due to inadequate insulin levels.
12 7) List the microvascular and neurologic complications associated with type 1 diabetes. Some of the long-term complications associated with T2DM include cardiovascular disease, nephropathy, retinopathy, peripheral neuropathy, and autonomic neuropathy. 8) When Susan s blood glucose level is tested at 2 am, she is hypoglycemic. In addition, her plasma ketones are elevated. When she is tested early in the morning before breakfast, she is hyperglycemic. Describe the dawn phenomenon. Is Susan likely to be experiencing this? How might this be prevented? The dawn phenomenon is an increased blood glucose in the early morning resulting from increased glucose production in the liver throughout an overnight fast. This can be mediated by administration of a combination of short- and intermediate-acting insulins before breakfast, short-acting insulin before evening meals, and intermediate-acting insulin at bedtime. 9) What precipitating factors may lead to the complication of diabetic ketoacidosis? List these factors and describe the metabolic events that result in the signs and symptoms associated with DKA. Omission or improper practice of insulin delivery, or general lack of blood glucose self monitoring can lead to DKA because blood glucose levels can sky-rocket, resulting in generation of ketones. Severe illness or infection can also impact a person s blood glucose and the amount of insulin needed. In addition, illness or emotional distress can vary an individual s eating patterns and throw off the balance between intake and insulin delivery. Nutrition Assessment Evaluation of Weight/Body Composition 10) Determine Susan s stature for age and weight for age percentiles. 62 = 1.65 m 25 th percentile CDC Stature-for-age percentiles: Girls, 2 to 20 years 100 # = 45.5 kg 20 th percentile CDC Weight-for-age percentiles: Girls, 2 to 20 years 11) Interpret these values using the appropriate growth chart. Stature and weight for age percentiles between the 10 th and 85 th percentile are considered normal. Considering this, Susan falls in a normal range according to the stature for age (25 th percentile) and weight for age (20 th percentile) growth curves. There is slight concern that Susan s weight may be a bit low for her stature considering the difference in these two percentiles. Calculation of Nutrient Requirements 12) Estimate Susan s daily energy and protein needs. Be sure to consider Susan s age. EER for Females 9 through 18 Years EER = (15) [10.0 (45.5) (1.65)] + 25 = 2313 kcal PA = active 2
13 13) What would the clinician monitor in order to determine whether or not the prescribed energy level is adequate? To monitor whether or not Susan is receiving adequate energy, her weight should be measured daily. Additional measures of her nutritional adequacy would include a lipid panel, albumin, and nitrogen balance. Intake Domain 14) Using a computer dietary analysis program or food composition table, calculate the kilocalories, protein, fat (saturated, polyunsaturated, and monounsaturated), carbohydrate, fiber, and cholesterol content of Susan s typical diet. 4,435 kcal 134 g. protein 167 g. fat (66 g. saturated, 32 g. polyunsaturated, 56 g. monounsaturated) 617 g. carbohydrate 25 g. fiber 324 mg. cholesterol *See attached FitDay nutrient analysis. 15) What dietary assessment tools can Susan use to coordinate her eating patterns with her insulin and physical activity? A diabetic exchange list is a relatively easy way to track the amount of carbohydrate Susan takes in and determine the appropriate amount of insulin to deliver. She can confirm this estimate by self-monitoring of blood glucose (SMBG) using a typical SMBG test such as a pin-prick and a reagent strip. Physical activity is an important aspect of Susan s T1DM treatment, and must be carefully monitored. Blood glucose levels should be taken both before and after exercise, and at times maybe during breaks in exercise to ensure that hyperglycemia and hypoglycemia to not develop as a result of the increased energy needs of Susan s skeletal muscles. 16) Dietitians must obtain and use information from all components of a nutrition assessment to develop appropriate interventions and goals that are achievable for the patient. This assessment is ongoing and continuously modified and updated throughout the nutrition therapy process. For each of the following components of an initial nutrition assessment, list at least three assessments you would perform for each component: Component Clinical data Nutrition history Weight history Physical activity history Assessments You Would Perform Fasting plasma glucose Plasma lipid profile Glycated hemoglobin assays Typical intakes of sugar Overall energy intake Profile of lipids consumed Current anthropometrics Acute changes in weight Weight for age percentile Typical daily activities 3
14 Monitoring Psychosocial/economic Knowledge and skills level Expectations and readiness to change Preferences of physical activity (ex: sports) Any cardiovascular risks of physical activity Monthly anthropometrics SMBG 3 times daily HbA 1C every 3 months Access to diabetic, low-sugar foods Access to diabetic testing materials Familial/social support of SMBG routine Knowledge of balanced diet Understanding of T1DM Ability to complete regular SMBG Attitude towards diagnosis Personal short- and long-term goals Desire to remain in compliance Clinical Domain 17) Does Susan have any laboratory results that support her diagnosis? One criteria for diagnosis of DM is a causal plasma glucose 200 mg/dl. Susan s glucose is 250 mg/dl, which supports this diagnosis. Additionally, Susan s glycated hemoglobin is also high (normal is % and recommendations for glycemic control are < 7.0%), which supports a diagnosis of DM. 18) Why did Dr. Green order a lipid profile? Although Susan does not exhibit typical risk factors for CVD, her diabetes can increase her risk for both macro- and microvascular complications that can be further exacerbated by dyslipidemia. Regular monitoring of plasma lipids is an important preventative approach for patients with DM. 19) Evaluate Susan s laboratory values: Chemistry Prealbumin (mg/dl) Osmolality (mmol/kg/h 2 O) Glucose (mg/dl) Normal Value Susan s Value Reason for Abnormality Hypovolemia resulting from polyuria Hypovolemia resulting from polyuria Inadequate insulin production BUN (mg/dl) Catabolism of protein due to cell starvation HbA 1C (%) Inadequate insulin production Nutritional Implications Rehydration and prevention of polyuria Rehydration and prevention of polyuria Regulation of glucose intake and insulin delivery Make energy available to cells Chronic hyperglycemia 4
15 20) Compare the pharmacological differences in insulins: Type of Insulin Brand Name Onset of Action Peak of Action Duration of Action Lispro Humalog min 1-3 hr 3-5 hr Aspart NovoLog min 1-3 hr 3-5 hr Glulisine Apidra min 1-3 hr 3-5 hr NPH Humulin N, 1-3 hr 8 hr 20 hr Novlin N Glargine Lantus 1 hr None 24 hr Detemir Levemir 1 hr None 24 hr 70/30 premix Mixtard, min Dual hr Humulin 70/30 50/50 premix Humulin 50/ min Dual hr 60/40 premix Mixtard min 2-8 hr 24 hr 21) Once Susan s blood glucose levels were under control, Dr. Green prescribed the following insulin regimen: 24 units of glargine in PM with the other 24 units as lispro divided between meals and snacks. How did Dr. Green arrive at this dosage? Dr. Green s insulin prescription is a flexible insulin therapy comprised of basal insulin once daily and multiple daily injections (MDIs) of bolus insulin before meals. Susan s daily basal insulin dose can be determined by multiplying her weight in kilograms by 0.6 units of insulin, yielding 27.3 units. Dr. Green suggested 24 units of basal insulin and approximately 24 units of bolus insulin depending on food intake. He selected a longacting basal insulin (glargine) to be delivered before bed and last through the night and a faster acting insulin (lispro) to be delivered throughout the day and as needed. Behavioral-Environmental Domain 22) Identify at least three specific potential nutrition problems within this domain that will need to be addressed for Susan and her family. Excessive energy intake (NI-1.5) RT polyphagia AEB dietary recall of 4,435 kcal (EER is 2313). Undesirable food choices (NB-1.7) RT inadequate knowledge of and/or disregard for nutritional guidelines AEB diet high in refined sugars and fats and low in nutrients. Irregular eating patterns (NB-1.5) RT busy volleyball schedule AEB pt. self-report. 23) Just before Susan is discharged, her mother asks you, My friend who owns a health food store told me that Susan should use stevia instead of artificial sweeteners or sugar. What do you think? What will you tell Susan and her mother? Stevia is a natural sweetener that can be used in place of sugar and other artificial sweeteners. Sweeteners alternative to sugar can be helpful tools for individuals with diabetes who are trying to manage their carbohydrate intake. Additional benefits of stevia (such as the delayed development of insulin resistance) are debated within the scientific community (Cheng, et. al., 2005). There also exist some support for detrimental impacts 5
16 of artificial sweeteners, but these adverse health effects are only seen in unreasonably high intakes of the products. In conclusion, there are a variety of sweetening alternatives, including stevia, acesulfame-k, sucarlose, etc., that are all safe for Susan to use depending on her personal preference. Nutritional Diagnosis 24) Select two high-priority nutrition problems and complete the PES statement for each. Impaired glucose utilization (NC-2.1) RT inadequate insulin synthesis by pancreas AEB hyperglycemia, FBG of 250 mg/dl and HbA 1C of 7.95%. Involuntary weight loss (NC-3.2) RT impaired glucose utilization AEB pt. self-report. Nutrition Intervention 25) For each of the PES statements that you have written, establish an ideal goal (based on the signs and symptoms) and an appropriate intervention (based on the etiology). FBG < 200 mg/dl and HbA 1C < 7.0% to be achieved by SMBG and delivery of synthesized insulin. Return to UBW (as determined by pt.) to be achieved by improved glucose utilization by SMBG and delivery of synthesized insulin. 26) Does the current diet order meet Susan s overall nutritional needs? If yes, explain why it is appropriate. If no, what would you recommend? Justify your answer. Nutrient Grams Kilocalories % Intake AMDR Total energy NA 2, % 100% Carbohydrate 300 1,200 50% 45-65% Protein % 10-35% Lipid % 20-35% Susan s current diet order (2,400 kcal, 300 g CHO, g protein, 80g lipid) does meet all of her overall nutritional needs. Her total energy intake is within an acceptable range of her EER (2,313) and all of her macronutrients also fall with the AMDR. Nutrition Monitoring and Evaluation 27) Susan is discharged Friday morning. She and her family have received information on insulin administration, SMBG, urine ketones, recordkeeping, exercise, signs, symptoms, and Tx of hypo-/hyperglycemia, meal planning (CHO counting), and contraception. Susan and her parents verbalize understanding of the instructions and have no further questions at this time. They are instructed to return in 2 weeks for appointments with the outpatient dietitan and CDE. When you come in to work Monday morning, you see that Susan was admitted through the ER Saturday night with a BG of 50 mg/dl. You see her when you make rounds and review her chart. During an interview, Susan tells you she was invited to a party Saturday night after her discharge on Friday. She tested her blood glucose before going to the party, and it measured 95 mg/dl. She took 2 units of insulin and knew she needed to have a snack that contained approximately 15 grams of CHO, so 6
17 she drank one bee when she arrived at the party. She remembers getting lightheaded and then woke up in the ER. What happened to Susan physiologically? Susan suffered from acute severe hypoglycemia, resulting from her insulin injection. While Susan was correct in selecting one beer as an appropriate delivery of 15 g. of CHO, she was incorrect in selecting 15 g. of CHO as an appropriate delivery for 2 units of insulin. One unit of insulin should be delivered for each carbohydrate exchange (15 g. of CHO). Thus, Susan should have had a snack containing 30 g. of carbohydrate rather than 15 g. Her insulin dose was twice what she needed to take in her 15 g. of carbohydrate, sending her into a state of sever hypoglycemia, which resulted in her loss of consciousness. 28) What kind of educational information will you give her before this discharge? Keep in mind that she is underage for legal consumption of alcohol. At this point I would talk to Susan about her responsibility as a 15-year old to managing her own health. I would reiterate the exchange system and how it correlates with insulin doses and go over a few exercises with Susan to ensure that she understands the correct calculations. Secondly I would address with Susan some of the physiological effects of alcohol, discussing the importance of her abstaining from alcohol until her brain is fully developed (around age 21) as well as some of the legal ramifications that can result from underage drinking. 7
18 References Chang, J.-C., Wu, M. C., Liu, I.-M., & Cheng, J.-T. (2005, April). Increase of insulin sensitivity by stevioside in fructose-rich chow-fed rats. Hormone and Metabolic Research, 37(10), Retrieved March 28, 2010 from Nelms, M., Sucher, K., & Long, S. (2007). Nutrition and pathophysiology. Belmont, CA: Wadsworth. Rolfes, S. R., Pinna, K., & Whitney, E. (2009). Understanding normal and clinical nutrition (8 th ed.). Belmont, CA: Wadsworth. 8
Type 1 Diabetes Mellitus in the Adult. Katie Davis & Liz DeJulius KNH 411: Medical Nutrition Therapy I
Type 1 Diabetes Mellitus in the Adult Katie Davis & Liz DeJulius KNH 411: Medical Nutrition Therapy I Diabetes Mellitus: Type I Genetic factor Sudden onset Majority children and adolescents with an increasing
More informationassociated with serious complications, but reduce occurrences with preventive measures
Wk 9. Management of Clients with Diabetes Mellitus 1. Diabetes Mellitus body s inability to metabolize carbohydrates, fats, proteins hyperglycemia associated with serious complications, but reduce occurrences
More informationMANAGEMENT OF TYPE 1 DIABETES MELLITUS
MANAGEMENT OF TYPE 1 DIABETES MELLITUS INVESTIGATIONS AND TREATMENT MANSI NAIK VII SEMESTER INVESTIGATIONS FASTING BLOOD SUGAR PLASMA GLUCOSE HEMOGLOBIN A 1c SYMPTOMS OF TYPE 1 DIABETES MELLITUS Polyuria
More informationType 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications. Alejandro J de la Torre Pediatric Endocrinology 10/17/2014
Type 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications Alejandro J de la Torre Pediatric Endocrinology 10/17/2014 Objectives Understand the pathophysiology of Type 1 diabetes. Be familiar
More informationDiabetes Mellitus Case Study
COLORADO STATE UNIVERSITY Diabetes Mellitus Case Study Medical Nutrition Therapy By: Emily Lancaster 9/28/2012 [Type the abstract of the document here. The abstract is typically a short summary of the
More informationAACN PCCN Review. Endocrine
AACN PCCN Review Endocrine Presenter: Carol A. Rauen, RN, MS, CCNS, CCRN, PCCN, CEN Independent Clinical Nurse Specialist & Education Consultant rauen.carol104@gmail.com Endocrine I. INTRODUCTION Disorders
More informationStroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols. Askiel Bruno, MD, MS Protocol PI
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols Askiel Bruno, MD, MS Protocol PI SHINE Synopsis Acute ischemic stroke
More informationAdjusting Insulin Doses
Adjusting Insulin Doses Everyone with diabetes, including you, will need to adjust your insulin doses at some time. There are several reasons why a person may need an insulin adjustment. These reasons
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationTips and Tricks for Starting and Adjusting Insulin. MC MacSween The Moncton Hospital
Tips and Tricks for Starting and Adjusting Insulin MC MacSween The Moncton Hospital Progression of type 2 diabetes Beta cell apoptosis Natural History of Type 2 Diabetes The Burden of Treatment Failure
More informationUncomplicated Diabetes Mellitus in Dogs Basics
Glendale Animal Hospital 623-934-7243 www.familyvet.com Uncomplicated Diabetes Mellitus in Dogs Basics OVERVIEW Increased levels of glucose (sugar) in the blood (known as hyperglycemia ) when the dog has
More informationLearning Objectives. Perioperative SWEET Success
Perioperative SWEET Success PERIOPERATIVE SWEET SUCCESS PRESENTED BY: KENDRA MARTIN, RN, BSN, CDE JENNIFER SIMPSON, RN, BC-ADM, MSN, CNS Disclosure to Participants Notice of Requirements For Successful
More informationComprehensive Diabetes Treatment
Comprehensive Diabetes Treatment Joshua L. Cohen, M.D., F.A.C.P. Professor of Medicine Interim Director, Division of Endocrinology & Metabolism The George Washington University School of Medicine Diabetes
More informationDiabetes in Pregnancy
Diabetes in Pregnancy Ebony Boyce Carter, MD, MPH Division of Maternal Fetal Medicine Washington University School of Medicine Disclosures I have no financial disclosures to report. Objectives Review the
More informationLantus to levemir conversion
Lantus to levemir conversion The Borg System is 100 % Lantus to levemir conversion 16-6-2005 Ask the Expert on... Lantus Conversion. Karen Shapiro, PharmD, BCPS. Disclosures. June 16, 2005. Question. Would
More informationThis certificate-level program is non-sponsored.
Program Name: Diabetes Education : A Comprehensive Review Module 5 Intensive Insulin Therapy Planning Committee: Michael Boivin, B. Pharm. Johanne Fortier, BSc.Sc, BPh.LPh, CDE Carlene Oleksyn, B.S.P.
More informationSubjects are requested to perform self-monitoring of blood glucose (SMBG) 4 times per
APPENDIX 1 Insulin Titration Algorithm Subjects are requested to perform self-monitoring of blood glucose (SMBG) 4 times per day. All subjects will be contacted weekly to review hypoglycemia and adverse
More informationModule 5. Understanding Insulin Therapy
Module 5. Understanding Insulin Therapy EDUCATIONAL OBJECTIVES Upon completion of this activity, participants will be better able to: 1. Define the basic physiologic concept of basal-bolus insulin; 2.
More information24 Hour Support. Telephone Available 24 hours a day, 7 days a week
Contents Page What is SHAIRE? 1 What is basal-bolus regimen? 2 Why do I need a basal-bolus regimen? 3 How does basal insulin work? 3 How does rapid-acting insulin work? 4 How often should I test my Blood
More informationComplete Comprehensive Diabetes Educator modules available at CCCEP File #: I-P (Expires: Mar.
CDE Preparation Program Topics (Accredited by CCCEP for 0.5 CEUs/Module section Total = 20 CEUs) Module 1 Pathophysiology of Diabetes 5 segments Module 2 Diabetes and Nutrition 5 segments Module 3 Medications
More informationINSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE
INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE OBJECTIVES DESCRIBE INSULIN, INCLUDING WHERE IT COMES FROM AND WHAT IT DOES STATE THAT
More informationDiabetes: What You Need to Know
UW MEDICINE PATIENT EDUCATION Diabetes: What You Need to Know Discharge review before you leave the hospital We want to be sure that we explained your diabetes instructions well, so that you know how to
More informationCASE STUDY #3 - NUT 116AL Diabetes Mellitus DUE Monday 12/9/13 (by 1:00pm in Meyer 3241)
Last Name Reagan First Name Jason Section 2_ CASE STUDY #3 - NUT 116AL Diabetes Mellitus DUE Monday 12/9/13 (by 1:00pm in Meyer 3241) Patricia C. is a 30 yo Asian American woman with T1DM. She was diagnosed
More informationBasal Bolus Insulin Therapy Frequently Asked Questions
1. What is Basal Bolus Insulin Therapy (BBIT)? 2. What evidence supports the use of subcutaneous Basal Bolus Insulin Therapy? 3. Does Basal Bolus Insulin Therapy apply to all patients? 4. What s wrong
More informationInsulin Prior Authorization with optional Quantity Limit Program Summary
Insulin Prior Authorization with optional Quantity Limit Program Summary 1-13,16-19, 20 FDA LABELED INDICATIONS Rapid-Acting Insulins Humalog (insulin lispro) NovoLog (insulin aspart) Apidra (insulin glulisine)
More informationDiabetes Head to Toe May 31, 2017
Innovations in Insulin Joanne Reid RN CDE jmreid@gbhs.on.ca Danielle Benedict RPh Outline Setting the stage Insulin as pancreas replacement therapy Commonly used insulins New insulins Case Studies Dosing
More informationDiabetes Mellitus in the Pediatric Patient
Diabetes Mellitus in the Pediatric Patient William Bryant, M.D. Chief of Section Pediatric Endocrinology Children s Hospital at Scott & White Texas A&M University Temple, Texas Disclosures None Definitions
More informationManagement of Diabetes New Concepts New Devices New Medications. Richard J. Comi, MD Professor of Medicine Geisel School of Medicine at Dartmouth
Management of Diabetes New Concepts New Devices New Medications Richard J. Comi, MD Professor of Medicine Geisel School of Medicine at Dartmouth Objectives: At the end of this lecture, the learner will
More informationDiabetes in Pregnancy
Diabetes in Pregnancy Susan Drummond RN MSN C-EFM Objectives 1. Describe types of diabetes and diagnosis of gestational diabetes 2. Identify a management plan for diabetes during pregnancy 3. Describe
More informationThe York Diabetes Care Model
This Session The York Diabetes Care Model The annual review what s it for and how to do it How to make the diagnosis of diabetes and who to test Categorisation of diabetes at diagnosis Basics of Insulin
More informationInsulin Basics. Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology
Insulin Basics Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology Disclosures Speakers Bureau for Sanofi, Astra Zeneca, Janssen, Boehringer-Ingelheim Objectives Discuss
More informationDisclosure 1/16/2017. Michael R. Brennan D.O., M.S., F.A.C.E Director Beaumont Endocrine Center Chief of Endocrine Beaumont Grosse Pointe 1/16/2017 2
Therapy For Diabetes Michigan Association of Osteopathic Family Physicians Mid-Winter Family Medicine Update Shanty Creek Resort, MI January 19-22nd 2017 Michael R. Brennan D.O., M.S., F.A.C.E Director
More informationPhysical Activity/Exercise Prescription with Diabetes
Physical Activity/Exercise Prescription with Diabetes B R AD H I NTERMEYER C E P A C SM S A NFORD H E ALTH C A RDIAC R E H AB A N D D I ABE TES E XE RCISE The adoption and maintenance of physical activity
More informationDiabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical
Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical Practice Guideline Task Force Members Anne Peters, MD (Chair)
More informationAdjusting Your Diabetes Medicine and Diet for a Test or Procedure
health information Adjusting Your Diabetes Medicine and Diet for a Test or Procedure The guidelines below will help you adjust your diabetes medicine and diet as you get ready for your procedure or lab
More informationNph insulin conversion to lantus
Nph insulin conversion to lantus Search 26-2-2003 RESPONSE FROM AVENTIS. We appreciate the opportunity to respond to Dr. Grajower s request for information regarding Lantus ( insulin glargine [rdna origin.
More informationSociety for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery
Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Girish P. Joshi, MB BS, MD, FFARCSI Anesthesia & Analgesia
More informationType 1 Diabetes Update Robin Goland, MD
Naomi Berrie Diabetes Center Type 1 Diabetes Update 2008 Robin Goland, MD Type 1 diabetes is: A manageable condition A chronic condition Often challenging Entirely compatible with a happy and healthy childhood
More informationPHARMACISTS INTERACTIVE EDUCATION CASE STUDIES
PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES Disclaimer: The information in this document is not a substitute for clinical judgment in the care of a particular patient. CADTH is not liable for any damages
More informationTechnology for Diabetes: 101 Basic Rules of the Road. Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE
Technology for Diabetes: 101 Basic Rules of the Road Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE Quick Pump Facts! o Constant insulin supply o Pager-sized mini-computer worn
More informationI. General Considerations
1 2 3 I. General Considerations A. Type I ( Juvenile Onset or IDDM) IDDM results from autoimmune destruction of beta cells inability to secrete insulin --> ketone formation --> DKA 4 Diabetic Ketoacidosis
More informationGuide to Starting and Adjusting Insulin for Type 2 Diabetes*
Guide to Starting and Adjusting Insulin for Type 2 Diabetes* www.cadth.ca * Adapted from Guide to Starting and Adjusting Insulin for Type 2 Diabetes, 2008 International Diabetes Center, Minneapolis, MN.
More informationLantus levemir conversion
Lantus levemir conversion Search Learn about starting insulin-naïve patients with type 2 diabetes on Levemir. Read Important Safety & Prescribing Info on the HCP Website. Lantus and Levemir have a variety
More informationINSULIN THERAY دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد
INSULIN THERAY DIABETES1 IN TYPE دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد Goals of management Manage symptoms Prevent acute and late complications Improve quality of life Avoid
More informationMixed Insulins Pick Me
Mixed Insulins Pick Me Alvin Goo, PharmD Clinical Associate Professor University of Washington School of Pharmacy and Department of Family Medicine Objectives Critically evaluate the evidence comparing
More information第十五章. Diabetes Mellitus
Diabetes-1/9 第十五章 Diabetes Mellitus 陳曉蓮醫師 2/9 - Diabetes 羅東博愛醫院 Management of Diabetes mellitus A. DEFINITION OF DIABETES MELLITUS Diabetes Mellitus is characterized by chronic hyperglycemia with disturbances
More informationDiabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE
Diabetes: Definition Pathophysiology Treatment Goals By Scott Magee, MD, FACE Disclosures No disclosures to report Definition of Diabetes Mellitus Diabetes Mellitus comprises a group of disorders characterized
More informationTHE CURRENT APPROACH TO T1D IN CHILDREN
THE CURRENT APPROACH TO T1D IN CHILDREN Dina Panagiotopoulos, MD, FRCPC Associate Professor, Department of Pediatrics University of British Columbia Endocrinologist, BC Children s Hospital CFRI & CDA Clinician
More informationDEMYSTIFYING INSULIN THERAPY
DEMYSTIFYING INSULIN THERAPY ASHLYN SMITH, PA-C ENDOCRINOLOGY ASSOCIATES SCOTTSDALE, AZ SECRETARY, AMERICAN SOCIETY OF ENDOCRINE PHYSICIAN ASSISTANTS ARIZONA STATE ASSOCIATION OF PHYSICIAN ASSISTANTS SPRING
More informationDiabetes: Everything You Want to Know. LCDR Bernadine John, RN, BSN, CDE
Diabetes: Everything You Want to Know LCDR Bernadine John, RN, BSN, CDE I have no financial affiliation to disclose as a conflict of interest regarding this presentation. DM Standards of Care The IHS Division
More informationClinicalTrials.gov Identifier: sanofi-aventis. Sponsor/company:
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinicalTrials.gov
More informationIn-hospital management of diabetes
Dr. Tom Elliott MBBS, FRCPC Medical Director 400-210 W Broadway phone: 604.683.3734 Vancouver, BC fax: 604.628.3821 V5Y 3W2 Canada email: moa@bcdiabetes.ca In-hospital management of diabetes General Management
More informationLast Name Wong First Name Jana Section 2. CASE STUDY #3 - NUT 116AL Diabetes Mellitus DUE Monday 12/9/13 (by 1:00pm in Meyer 3241)
Last Name Wong First Name Jana Section 2 CASE STUDY #3 - NUT 116AL Diabetes Mellitus DUE Monday 12/9/13 (by 1:00pm in Meyer 3241) Patricia C. is a 30 yo Asian American woman with T1DM. She was diagnosed
More informationPHARMACISTS INTERACTIVE EDUCATION CASE STUDIES
PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES Disclaimer: The information in this document is not a substitute for clinical judgment in the care of a particular patient. CADTH is not liable for any damages
More informationCase Study: Competitive exercise
Case Study: Competitive exercise 32 year-old cyclist Type 1 diabetes since age 15 Last HbA1 54 No complications and hypo aware On Humalog 8/8/8 and Levemir 15 Complains about significant hypoglycaemia
More informationType 2 Diabetes Mellitus Insulin Therapy 2012
Type 2 Diabetes Mellitus Therapy 2012 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Preparations Onset Peak Duration
More informationNew Hires Program Canadian Diabetes Educator Certification Board Competencies Addressed
New Hires Program Canadian Diabetes Educator Certification Board Competencies Addressed Competency Pathophysiology 1.A Describes the pathophysiology and progression of all types of 1.B Distinguishes between
More informationLET S TALK INSULIN THE BASICS
LET S TALK INSULIN THE BASICS AUTHOR S DISCLOSURES Contracted for program development for Lifescan Canada Speaker for Lifescan, Lilly, BI, Consultant for Lilly, Janssen, Novo Nordisk, Lifescan Canada OBJECTIVES
More informationThe ABCs of MDI: Gaining a working knowledge of Multiple Daily Injection insulin therapy. Today s Presenter
FD Title Slide The ABCs of MDI: Gaining a working knowledge of Multiple Daily Injection insulin therapy learn.extension.org/events/3369 3 This material is based upon work supported by the National Institute
More informationComplete this CE activity online at ProCE.com/InsulinPart2
Complete this CE activity online at ProCE.com/InsulinPart2 Case 1: A 67 year old male with T2DM History and Presentation John is a 67 year old retiree who has been visiting your pharmacy/clinic for over
More information4/16/2018. Flexible Intensive Insulin Therapy (FIIT) in People with Type 2 Diabetes: A Viable Option. Disclosures. Outline. No financial disclosures
Flexible Intensive Insulin Therapy (FIIT) in People with Type Diabetes: A Viable Option Kim Bisanz, MFCS, RDN, LDN, CDE Minnesota Academy of Nutrition & Dietetics Annual Meeting April 19, 18 18 MFMER slide-1
More informationSupplemental Health Record and Authorization for Care of Child with Insulin Dependent Diabetes
477 Beaverkill Road Olivebridge, New York 12461 (845) 657-8333 Ext. 15 Fax (845) 657-8489 martin.bernstein@ashokancenter.org www.ashokancenter.org 2012-13 Supplemental Health Record and Authorization for
More informationExercise in Diabetes Mellitus. Pranisa Luengratsameerung,MD
Exercise in Diabetes Mellitus By Pranisa Luengratsameerung,MD What is the Diabetes Mellitus? action Insulin Defect release Abnormal glucose metabolism Symptoms Polyuria (frequent urination) Polyphasia
More informationInsulin Pump Therapy
Patient and Family Education Insulin Pump Therapy The insulin pump is a device that gives insulin to the body at a steady rate. With the pump you won t need daily shots. This handout describes how insulin
More informationComparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults With Type 2 Diabetes Executive Summary
Number 14 Effective Health Care Comparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults With Type 2 Diabetes Executive Summary Background and Key Questions
More informationPrior to making any insulin adjustments the following knowledge and skills are required:
Diabetes Control Diabetes Control Food, activity and insulin influence your blood glucose levels. At times it may seem like a juggling act as you attempt to balance these three factors. Home blood glucose
More informationBlood Sugar and Insulin
PATIENT & CAREGIVER EDUCATION Blood Sugar and Insulin This information explains high and low blood sugar levels and how to manage them. About Blood Sugar and Insulin Your body uses a sugar called glucose
More informationPoll Question 2. Special Boot Camp Workshop Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services.
Special Boot Camp Workshop Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Poll Question 1 Mary takes 6 units lispro (Humalog) before dinner. Which BG result reflects
More informationAgenda. Indications Different insulin preparations Insulin initiation Insulin intensification
Insulin Therapy F. Hosseinpanah Obesity Research Center Research Institute for Endocrine sciences Shahid Beheshti University of Medical Sciences November 11, 2017 Agenda Indications Different insulin preparations
More informationDIABETES MELLITUS. IAP UG Teaching slides
DIABETES MELLITUS 1 DIABETES MELLITUS IN CHILDREN Introduction, Definition Classification, pathogenesis Clinical features Investigations and diagnosis Therapy and follow up Complications Carry home message
More informationInformation for all patients taking insulin who are admitted to hospital on day of surgery
Information for all patients taking insulin who are admitted to hospital on day of surgery Exceptional healthcare, personally delivered Introduction Many patients are now admitted to hospital on the day
More informationGLUCOSE MONITORING. How. When
GLUCOSE MONITORING Why Self-monitoring of blood glucose is the best way to see how your body handles food, activity, diabetes medication (pills and/or insulin), stress and illness. You can also see what
More informationObjectives 2/13/2013. Figuring out the dose. Sub Optimal Glycemic Control: Moving to the Appropriate Treatment
Sub Optimal Glycemic Control: Moving to the Appropriate Treatment Judy Thomas, MSN, FNP-BC Holt and Walton, Rheumatology and Endocrinology Objectives Upon completion of this session you will be better
More informationCANDY Camp Application
CANDY Camp Application Please complete the following form and submit it by June 15, 2016. Please mail form to Bonnie Kruse, Diabetes Program Coordinator, HSHS St. Anthony s Memorial Hospital, 503 North
More informationExercise and Activity Guidelines
Patient and Family Education Exercise and Activity Guidelines For Children and Teens with Diabetes Guidelines to follow when you are active, playing a sport or exercising It is important to monitor and
More informationCarissa Schwandt HN 631 Case Study 2 Pediatric Type 1 Diabetes Mellitus
Carissa Schwandt HN 631 Case Study 2 Pediatric Type 1 Diabetes Mellitus 1. What are the current thoughts regarding the etiology of type 1 mellitus (T1DM)? No one else in Rachel s family has diabetes-is
More informationPharmacy Plan Guidance
Pharmacy Plan Guidance The pharmacy plan is a tool used during the site readiness process to develop and document the site-specific procedures for study drug ordering, labeling and dispensing for the SHINE
More informationPediatric Diabetes Update Fran R. Cogen, MD, CDE Professor of Pediatrics Director, Diabetes Services
1.19.18 Pediatric Diabetes Update Fran R. Cogen, MD, CDE Professor of Pediatrics Director, Diabetes Services DISCLOSURES 1. No financial incentives 2. Volunteer Positions 1. National Certification Board
More informationWhy do we care? 20.8 million people. 70% of people with diabetes will die of cardiovascular disease. What is Diabetes?
What is Diabetes? Diabetes 101 Ginny Burns RN MEd CDE Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action
More informationDiabetes Mellitus in Small Animals
Diabetes Mellitus in Small Animals Julie A Stephens, DVM, DACVIM Veterinary Emergency And Specialty Center of New Mexico Albuquerque, New Mexico Diabetes Mellitus Persistent hyperglycemia caused by a relative
More informationDiabetes Survival Skills
Promoting Patient Survival with Diabetes Survival Skills Need to know skills for persons with diabetes Susan Zontine, NP-C WMC Diabetes Stewardship team May 18, 2015 Diabetes Chronic illness with serious
More informationAPPENDIX American Diabetes Association. Published online at
APPENDIX 1 INPATIENT MANAGEMENT OF TYPE 2 DIABETES No algorithm applies to all patients with diabetes. These guidelines apply to patients with type 2 diabetes who are not on glucocorticoids, have no
More informationThe principles of insulin adjustment guidance
The principles of insulin adjustment guidance Tips for insulin titration Blood glucose (BG) monitoring is needed to help identify the efficacy of treatment in diabetes. Monitor blood glucose according
More informationCASE STUDY Diabetes Mellitus FH: PMH: Social Hx PE: Labs: Rx: CAM: Dx: Plan:
CASE STUDY Diabetes Mellitus Patricia C. is a 30 yo Asian American woman with T1DM. She was diagnosed at age 13. Her insulin regimen is 50 units of insulin (Glargine) every evening and 3 units of Lispro
More informationMedical Nutrition Therapy for Diabetes Mellitus. Raziyeh Shenavar MSc. of Nutrition
Medical Nutrition Therapy for Diabetes Mellitus Raziyeh Shenavar MSc. of Nutrition Diabetes Mellitus A group of diseases characterized by high blood glucose concentrations resulting from defects in insulin
More informationType I Type II Insulin Resistance
Insulin An aqueous hormonal solution made in the pancreas. Affects metabolism by allowing glucose to leave the blood and enter the body cells, preventing hyperglycemia. It is measured in units, e.g. 100
More informationFH: PMH: Social Hx PE: Labs: Rx: CAM: Dx: Plan:
Patricia C. is a 30 yo Asian American woman with T1DM. She was diagnosed at age 13. Her insulin regimen is 50 units of insulin (Glargine) every evening and 3 units of Lispro with each meal. Her HbA1c is
More informationNew Drug Evaluation: Insulin degludec/aspart, subcutaneous injection
New Drug Evaluation: Insulin degludec/aspart, subcutaneous injection Date of Review: March 2016 End Date of Literature Search: November 11, 2015 Generic Name: Insulin degludec and insulin aspart Brand
More informationApplication of the Diabetes Algorithm to a Patient
Application of the Diabetes Algorithm to a Patient Apply knowledge gained from this activity to improve disease management and outcomes for patients with T2DM and obesity Note: The cases in this deck represent
More informationInitiating Injectable Therapy in Type 2 Diabetes
Initiating Injectable Therapy in Type 2 Diabetes David Doriguzzi, PA C Learning Objectives To understand current Diabetes treatment guidelines To understand how injectable medications fit into current
More informationJournal Club September 29, Vanessa AKIKI PGYlII Internal Medicine
Journal Club September 29, 2017 Vanessa AKIKI PGYlII Internal Medicine AUBMC 2017 Case Presentation 41-year-old man who was diagnosed with type 1 diabetes 21 years ago presents to your clinic. He believes
More informationInsulin Initiation and Intensification. Disclosure. Objectives
Insulin Initiation and Intensification Neil Skolnik, M.D. Associate Director Family Medicine Residency Program Abington Memorial Hospital Professor of Family and Community Medicine Temple University School
More informationDIAGNOSIS OF DIABETES NOW WHAT?
DIAGNOSIS OF DIABETES NOW WHAT? DISCUSS GOALS FOR DIABETES CARE IDENTIFY COMMON COMPLIANCE- ADHERENCE ISSUES DESCRIBE TECHNOLOGY TO ASSIST AND / OR IMPROVE DIABETES CARE WHAT DO WE WANT OUR PATIENTS TO
More informationDiabetic Ketoacidosis
October 2015 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Case History HPI: 24 yo man with recent 8 lb. weight loss, increased thirst and frequent
More informationDiabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016
Diabetes Mellitus Raja Nursing Instructor 09/03/2016 Acknowledgement: Badil Objective: Define Diabetes Mellitus (DM) & types of DM. Understand the pathophysiology of Type-I & II DM. List the clinical features
More informationInsulin 10/11/17. Disclosures. Objectives. Speaker and Consultant for Jansen and Healthscripts Speaker and Consultant for Boehringer Ingelheim (BI)
Insulin The What, When, Where, Who and Why Disclosures Speaker and Consultant for Jansen and Healthscripts Speaker and Consultant for Boehringer Ingelheim (BI) Objectives Define background and history
More informationInsulin Pump Therapy. WakeMed Children s Endocrinology & Diabetes WakeMed Health & Hospitals Version 1.3, rev 5/21/13 MP
Insulin Pump Therapy WakeMed Children s Endocrinology & Diabetes Overview What is an insulin pump? What are the advantages and disadvantages of an insulin pump? Lifestyle Changes Food Management Exercise
More informationDiabetes Mellitus. Mohamed Ahmed Fouad Lecturer of Pediatrics Jazan Faculty of Medicine
Diabetes Mellitus Mohamed Ahmed Fouad Lecturer of Pediatrics Jazan Faculty of Medicine Define DM in children Differentiate types of DM Discus Etiology and Risk Factor Reason clinical presentations Set
More informationMy Sick Day Plan for Type 1 Diabetes on Multiple Daily Injections (MDI)
My Sick Day Plan for Type 1 Diabetes on Multiple Daily Injections (MDI) When you are sick, your blood sugar levels may be harder to keep under control. Your blood sugar may go too high or too low. Use
More informationDrug Effectiveness Review Project Summary Report Long acting Insulins
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More information